Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THRio: Isoniazid preventive therapy in HIV patients in Brazil
NCT00107887Phase 4Completed
- Sponsor
- Johns Hopkins University
- Start
- Jun 2005
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of isoniazid in Tuberculosis (TB), sponsored by Johns Hopkins University. Primary endpoints: Measured incidence of active TB in HIV clinic population at 6 years and Comparative impact of Isoniazid Preventive Therapy and antiretrovirals on TB incidence at 6 years. Started Jun 2005; status: completed.
02
Drugs
isoniazid
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT00107887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00107887.